Showing results (101-110 of 148) with videos related to
Sort By:
Pageof 15
Plos Neglected Tropical Diseases|October 8, 2013
Pathogenomic inference of virulence-associated genes in Leptospira interrogansJason S Lehmann, Derrick E Fouts, Daniel H Haft, et al.Journal of Translational Medicine|August 30, 2012
Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injuryDerrick E Fouts, Rembert Pieper, Sebastian Szpakowski, et al.Journal of Bacteriology|April 20, 2006
Sequencing Bacillus anthracis typing phages gamma and cherry reveals a common ancestryDerrick E Fouts, David A Rasko, Regina Z Cer, et al.Antibiotics (Basel, Switzerland)|November 24, 2022
Design of a Bacteriophage Cocktail Active against Shigella Species and Testing of Its Therapeutic Potential in Galleria mellonellaAndrey A Filippov, Wanwen Su, Kirill V Sergueev, et al.Plos Neglected Tropical Diseases|November 13, 2012
Whole genome analysis of Leptospira licerasiae provides insight into leptospiral evolution and pathogenicityJessica N Ricaldi, Derrick E Fouts, Jeremy D Selengut, et al.The Journal of Infectious Diseases|May 22, 2025
Escherichia coli Type III Secretion System 2 (ETT2) is Associated with Patient Mortality in Bloodstream InfectionsJoshua T Thaden, Phillip Cox, Paa Kwesi Ankrah, et al.Mbio|September 22, 2025
Integrating genomic and Tn-Seq data to identify common in vivo fitness mechanisms across multiple bacterial speciesDerrick E Fouts, Thomas H Clarke, Geoffrey B Severin, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 6, 2019
Monitoring Ceftazidime-Avibactam and Aztreonam Concentrations in the Treatment of a Bloodstream Infection Caused by a Multidrug-Resistant Enterobacter sp. Carrying Both Klebsiella pneumoniae Carbapenemase-4 and New Delhi Metallo-β-Lactamase-1Mohamad Yasmin, Derrick E Fouts, Michael R Jacobs, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
A phase 1 study of ABT-751, an orally bioavailable tubulin inhibitor, administered daily for 7 days every 21 days in pediatric patients with solid tumorsElizabeth Fox, John M Maris, Brigitte C Widemann, et al.Antimicrobial Agents and Chemotherapy|October 17, 2018
ARGONAUT-I: Activity of Cefiderocol (S-649266), a Siderophore Cephalosporin, against Gram-Negative Bacteria, Including Carbapenem-Resistant Nonfermenters and Enterobacteriaceae with Defined Extended-Spectrum β-Lactamases and CarbapenemasesMichael R Jacobs, Ayman M Abdelhamed, Caryn E Good, et al.Pageof 15